1. Home
  2. Clinical Topics
  3. FDA approves new drug treatments for type 2 diabetes
Clinical TopicsDrugs and DevicesEndocrinologyHealthcare & TechnologyNewsWeb Exclusives

FDA approves new drug treatments for type 2 diabetes

Share

On Jan. 25, 2013, the U.S. Food and Drug Administration (FDA) approved three new related products for the treatment of type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts